Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
3.340
+0.110 (3.41%)
Nov 22, 2024, 4:00 PM EST - Market closed
Daré Bioscience Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Daré Bioscience stock have an average target of 20.33, with a low estimate of 12 and a high estimate of 36. The average target predicts an increase of 508.68% from the current stock price of 3.34.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DARE stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +259.28% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +259.28% | Oct 24, 2024 |
| Jones Trading | Jones Trading | Strong Buy Maintains $5 → $13 | Strong Buy | Maintains | $5 → $13 | +289.22% | Aug 16, 2024 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +2,055.69% | May 15, 2024 |
Financial Forecast
Revenue This Year
13.72M
from 2.81M
Increased by 388.48%
Revenue Next Year
22.96M
from 13.72M
Increased by 67.37%
EPS This Year
-0.68
from -4.15
EPS Next Year
-1.39
from -0.68
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 34.7M | 62.5M | 96.8M | ||
| Avg | 13.7M | 23.0M | 47.0M | ||
| Low | 31,360 | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1,134.0% | 355.6% | 321.7% | ||
| Avg | 388.5% | 67.4% | 104.8% | ||
| Low | -98.9% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.20 | -0.24 | -0.36 | ||
| Avg | -0.68 | -1.39 | -1.52 | ||
| Low | -1.13 | -2.83 | -2.60 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.